Machine Learning

Search documents
OSS Partners with U.S. Special Operations Command to Develop High Performance edge Computers (HPeC) for Austere Maritime Environments
Globenewswire· 2025-05-29 12:00
Core Viewpoint - One Stop Systems, Inc. has entered into a Cooperative Research and Development Agreement (CRADA) with U.S. Special Operations Command (USSOCOM) to develop advanced High Performance edge Computer (HPeC) solutions aimed at enhancing the operational capabilities of U.S. Special Operations Forces [1][2][3] Group 1: Partnership and Strategic Goals - The partnership aims to leverage OSS's expertise in rugged AI and ML computing solutions to improve USSOCOM's maritime platform performance and capabilities [2][3] - The initiative focuses on enhancing situational awareness, decision-making, and operational capabilities of special operations forces in maritime operations [2] - OSS's collaboration with USSOCOM is part of a multi-year strategy to expand offerings and establish relationships across all branches of the U.S. Armed Forces [3] Group 2: Product and Technology Overview - OSS specializes in rugged Enterprise Class compute and storage products designed for extreme conditions, enabling AI, sensor fusion, and autonomous capabilities [4][5] - The company's products include ruggedized servers, compute accelerators, and storage solutions used in various industries, including defense [5][6] - OSS solutions address the entire AI workflow, from data acquisition to deep learning and inference, positioning the company as a leader in the rapidly growing edge computing market [6]
Synchronoss Added to Membership of US Small-Cap Russell 2000® Index
Globenewswire· 2025-05-29 12:00
Group 1 - Synchronoss Technologies, Inc. has been added to the US small-cap Russell 2000 Index, effective June 30, 2025, as part of the 2025 Russell indexes reconstitution [1][2] - Membership in the Russell 2000 Index is based on inclusion in the broader Russell 3000 Index and will remain for one year [1] - The stock will also be included in the relevant growth and value indexes, enhancing its visibility within the investment community [1][2] Group 2 - The CEO of Synchronoss, Jeff Miller, stated that the inclusion in the Russell 2000 Index validates the company's strategic vision and progress in delivering innovative cloud solutions [2] - Synchronoss focuses on providing cloud solutions for telecom and mobile operators, leveraging AI and machine learning technologies [2][4] - As of June 2024, approximately $10.6 trillion in assets are benchmarked against the Russell US indexes, indicating the significance of this inclusion for investment managers and institutional investors [2]
Moncler: Transforming Into A Luxury Powerhouse
Seeking Alpha· 2025-05-28 14:04
Core Insights - The article discusses the expertise of a DevOps Engineer specializing in AI tools and applications, highlighting their deep knowledge in generative AI systems and machine learning algorithms [1] - The engineer is pursuing advanced AWS machine learning certifications to enhance their expertise in AI and machine learning [1] - The engineer contributes insights on AI and machine learning through an investment-focused lens on Seeking Alpha [1] Group 1 - The engineer is a subject-matter expert in the buildout, deployment, and maintenance of AI tools and applications [1] - The engineer ranks 856 out of 30,634 financial bloggers and 1,404 out of 40,003 experts according to TipRanks [1] - The engineer has no stock or derivative positions in any mentioned companies and has no plans to initiate any such positions within the next 72 hours [1]
Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash
Prnewswire· 2025-05-28 12:33
Core Insights - Azitra, Inc. is presenting a poster on its Phase 1/2 clinical trial of ATR04-484 for treating EGFR inhibitor-associated rash at ASCO 2025 [1][2] - ATR04-484 is a live biotherapeutic product derived from Staphylococcus epidermidis, engineered for safety and efficacy [2][4] - The FDA has granted Fast Track designation for ATR04-484, which addresses a significant dermatologic toxicity affecting approximately 150,000 patients in the U.S. [5] Company Overview - Azitra, Inc. focuses on innovative therapies for precision dermatology, with its lead program ATR-12 targeting Netherton syndrome, a rare skin disease [5] - The company utilizes a proprietary platform of engineered proteins and a microbial library of around 1,500 bacterial strains, enhanced by AI and machine learning [5] Clinical Trial Details - The Phase 1/2 trial is multicenter, randomized, double-blind, and vehicle-controlled, assessing the safety and tolerability of ATR04-484 [2][3] - The presentation at ASCO 2025 will be led by Mary Spellman, MD, Chief Medical Officer, and will focus on the treatment of EGFRi-induced dermal toxicity [4]
Aether Holdings Added to Russell Microcap® Index
Globenewswire· 2025-05-28 12:00
Core Viewpoint - Aether Holdings, Inc. is set to be included in the Russell Microcap® Index effective June 30, 2025, which is a significant milestone for the company shortly after its IPO, enhancing its visibility among institutional investors and reflecting market recognition of its fintech strategy [1][3]. Company Overview - Aether Holdings, Inc. is an emerging financial technology platform that provides proprietary research analytics aimed at transforming how investors navigate the markets [8]. - The company leverages advanced technologies, including machine learning and artificial intelligence, to deliver tools, data, and research that empower traders with actionable insights [9][11]. Index Inclusion Details - Membership in the Russell Microcap® Index is based on market capitalization rankings and style attributes, and it remains in place for one year, providing automatic inclusion in relevant growth and value style indexes [2]. - The Russell indexes serve as benchmarks for approximately $10.6 trillion in assets, indicating their significance in the investment management industry [3]. Strategic Implications - The inclusion in the Russell Microcap® Index is expected to increase Aether's exposure to a broader investor base, which is crucial for its growth plans and mission to democratize market intelligence [3]. - Aether's CEO emphasized that this milestone validates the company's growth strategy since going public and enhances its visibility among institutional investors [3]. FTSE Russell Insights - FTSE Russell, the provider of the Russell indexes, is focused on adapting its indexes to reflect the evolving U.S. economy and will transition to a semi-annual reconstitution frequency starting in 2026 [4]. - FTSE Russell manages a wide array of indexes that cover 98% of the investable market globally, with approximately $18.1 trillion benchmarked to its indexes [5].
BB vs. CRWD: Which Cybersecurity Stock Is the Smarter Buy Now?
ZACKS· 2025-05-27 13:11
Industry Overview - The cybersecurity market is projected to witness a CAGR of 12.9% from 2025 to 2030, driven by increasing digital threats and the need for advanced cybersecurity solutions [3] - The rise in cloud deployment, digital transformation, and the proliferation of smart and IoT devices has led to more sophisticated cyberattacks, necessitating enhanced cybersecurity measures [2] Company Analysis: BlackBerry Limited (BB) - BlackBerry has shifted its focus from smartphones to cybersecurity and IoT solutions, with its Secure Communications division including products like Unified Endpoint Management (UEM) and SecuSUITE [4] - In fiscal Q4, BlackBerry's Secure Communications revenue reached $67.3 million, exceeding forecasts, driven by strong performance in AtHoc and UEM solutions [5] - The company has established strong relationships with government agencies, securing a stable revenue stream and credibility in high-trust sectors [6] - BlackBerry has successfully cut approximately $150 million from its run rate and reported an adjusted EBITDA of $39.3 million for fiscal 2025, marking a significant improvement [8] - The expansion of contracts with the Malaysian government enhances BlackBerry's revenue potential and positions its Secure Communications division as a key contributor to overall EBITDA [7] Company Analysis: CrowdStrike Holdings, Inc. (CRWD) - CrowdStrike is a leader in next-generation endpoint protection and has introduced new solutions like Falcon Data Protection to address data security concerns [9] - The company's subscription revenues reached $1.01 billion, reflecting a 27% increase year-over-year, aided by the Falcon Flex Subscription Model [10] - Despite strong growth, CrowdStrike faces challenges due to customer sentiment issues following a global IT outage and has implemented a Customer Commitment Package to retain clients [11] - The company has significantly increased its sales and marketing expenses, which rose nearly ninefold to $1.52 billion in fiscal 2025, alongside a focus on R&D [12][13] Performance Comparison - Over the past month, BlackBerry and CrowdStrike have seen stock gains of 10.5% and 7.6%, respectively [16] - BlackBerry's forward 12-month Price/Sales ratio is 4.21X, significantly lower than CrowdStrike's 22.17X, indicating a more favorable valuation for BlackBerry [17] - Analysts have raised BlackBerry's earnings estimates for the current fiscal year, while CrowdStrike has seen only marginal upward revisions [19][21] Investment Outlook - Both companies are well-positioned to benefit from the growing cybersecurity market, but BlackBerry currently holds a Zacks Rank 1 (Strong Buy), while CrowdStrike has a Zacks Rank 4 (Sell), suggesting BlackBerry may be the better investment choice at this time [22]
Court Denies Renovaro Motion for an Expedited Trial in July
GlobeNewswire News Room· 2025-05-27 12:35
Core Viewpoint - Predictive Oncology Inc. is engaged in a legal dispute with Renovaro, Inc., with the Delaware Court of Chancery rejecting RENB's request for an expedited trial, citing delays in RENB's actions [1][2]. Company Overview - Predictive Oncology is a leader in AI-driven drug discovery, utilizing its AI platform, PEDAL, which predicts with 92% accuracy whether a tumor sample will respond to specific drug compounds [3]. - The company has a biobank of over 150,000 assay-capable heterogeneous human tumor samples, providing extensive AI-based drug discovery solutions [3]. - Predictive Oncology is headquartered in Pittsburgh, PA, and operates a wholly owned CLIA laboratory facility [3]. Legal Proceedings - The court has scheduled the trial for November 12-13, 2025, and Predictive Oncology intends to defend against RENB's claims, which are deemed inaccurate and without merit [2].
AST SpaceMobile: Turning The Sky Into Your Next Cell Tower
Seeking Alpha· 2025-05-27 07:49
Core Insights - AST SpaceMobile is developing a space-based cellular network aimed at providing 4G and 5G signals directly to over five billion smartphones globally, transforming a science fiction concept into practical utility [1] Group 1 - The company is positioned to erase the connectivity gap by leveraging satellite technology to enhance mobile communication [1]
Snowflake Rallies Post Q1 Earnings: Buy, Sell or Hold the Stock?
ZACKS· 2025-05-26 18:31
Core Insights - Snowflake (SNOW) shares have increased by 11.7% since the release of its first-quarter fiscal 2026 results, driven by strong platform adoption and a net revenue retention rate of 124% as of April 30, 2025 [1] - The company has seen a year-to-date share price increase of 29.5%, outperforming the Zacks Computer and Technology sector, which decreased by 3.8%, and the Zacks Internet Software industry, which increased by 4.3% [2] - Snowflake's customer base has grown significantly, with 11,578 customers as of April 30, 2025, up from 9,741 customers a year earlier, and a net addition of 451 customers in the first quarter of fiscal 2026, representing a 19% year-over-year increase [2] Financial Performance - For the second quarter of fiscal 2026, Snowflake expects product revenues to be between $1.03 billion and $1.04 billion, indicating a year-over-year growth of 25% [15] - The Zacks Consensus Estimate for second-quarter fiscal 2026 revenues is currently at $1.08 billion, reflecting a 24.60% year-over-year growth [16] - For fiscal 2026, Snowflake anticipates product revenues to reach $4.32 billion, a 25% increase from fiscal 2025 [15] Competitive Landscape - Snowflake's strong partner ecosystem, including major companies like Microsoft, Amazon, and NVIDIA, has been a key growth driver [7] - The company faces intense competition from major cloud providers such as AWS, Azure, and Google Cloud, as well as rivals like Databricks [18][19] - Rising expenses and GPU-related costs due to aggressive investments in AI initiatives are impacting profitability [18][19] Product and Innovation - Snowflake's expanding portfolio includes products like Apache Iceberg, Hybrid tables, and Cortex AI, which are attracting new clients [12] - The integration of OpenAI's models into Snowflake Cortex AI through a partnership with Microsoft enhances enterprise AI capabilities [8] - More than 5,200 customers are utilizing Snowflake's AI and machine learning technology weekly, indicating strong engagement [14]
Pure Storage Gears Up to Report Q1 Earnings: Here's What to Expect
ZACKS· 2025-05-26 15:41
Core Viewpoint - Pure Storage, Inc. (PSTG) is expected to report a decline in earnings for the first quarter of fiscal 2026, while total revenues are projected to grow year-over-year [1][2]. Financial Performance - The Zacks Consensus Estimate for earnings in the upcoming quarter is 25 cents, reflecting a 21.9% decrease from the same quarter last year [1]. - Total revenues are estimated at $771.2 million, indicating an 11.2% year-over-year growth [1]. - For the first quarter, Pure Storage anticipates revenues of $770 million, which represents an 11% increase from the previous year [2]. Revenue Breakdown - Subscription services revenues accounted for 43.8% of total revenues in the last reported quarter, amounting to $385.1 million, which was a 17% increase [3]. - For the fiscal first quarter, Subscription services revenues are expected to be $358.5 million, up 3.6% year-over-year [3]. Product and Market Developments - The adoption of FlashArray//XL and FlashArray//E, along with strong Evergreen subscription renewals, is likely to contribute positively to PSTG's performance [3]. - Recent product launches, including the second-generation Pure Fusion and enhancements to the Portworx platform, are expected to drive enterprise adoption, particularly for cloud-native and AI/ML workloads [4]. Margin Expectations - Pure Storage expects product gross margins to stabilize in the mid-60s for fiscal 2026, aligning with its long-term target of 65-70% [5]. Competitive Landscape - The company faces stiff competition and an uncertain macroeconomic environment, with geopolitical uncertainties expected to impact the market throughout the year [6]. Strategic Partnerships - On April 21, 2025, Pure Storage partnered with Varonis Systems to enhance data protection capabilities for organizations [7]. - The incorporation of the NVIDIA AI Data Platform reference design into its FlashBlade platform reinforces Pure Storage's commitment to scalable AI-ready solutions [8]. - The upcoming launch of FlashBlade//EXA, designed for AI and High-Performance Computing (HPC), is set for summer 2025 [9].